These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31255420)

  • 1. Re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
    Hora M
    Eur Urol; 2019 Oct; 76(4):e96. PubMed ID: 31255420
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
    Tran MGB; Barod R; Bex A
    Eur Urol; 2019 Jun; 75(6):e179-e180. PubMed ID: 30833137
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Milan Hora's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
    Macklin PS; Sullivan ME; Tapping CR; Webster GM; Roberts ISD; Verrill CL; Browning L
    Eur Urol; 2019 Oct; 76(4):e97. PubMed ID: 31255422
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Maxine G. Tran, Ravi Barod, and Axel Bex's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
    Macklin PS; Sullivan ME; Tapping CR; Webster GM; Roberts ISD; Verrill CL; Browning L
    Eur Urol; 2019 Jun; 75(6):e177-e178. PubMed ID: 30827695
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre.
    Macklin PS; Sullivan ME; Tapping CR; Cranston DW; Webster GM; Roberts ISD; Verrill CL; Browning L
    Eur Urol; 2019 May; 75(5):861-867. PubMed ID: 30591353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Nov; 70(5):e141-e142. PubMed ID: 27157996
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73: The Search for Accurate Diagnostic Rates in Renal Mass Biopsy.
    Abel EJ
    Eur Urol; 2016 Jun; 69(6):e117-8. PubMed ID: 26778464
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Kim JH
    Eur Urol; 2016 Nov; 70(5):e139-e140. PubMed ID: 27157997
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Mouracade P
    Eur Urol; 2015 Oct; 68(4):e82-3. PubMed ID: 26033152
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Potretzke AM; Larson JA; Bhayani SB
    Eur Urol; 2015 Feb; 67(2):e19-20. PubMed ID: 25269382
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Zargar H; Coelho RF; Kaouk JH
    Eur Urol; 2015 Feb; 67(2):e23. PubMed ID: 25266972
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
    Kim WH; Yoon HK; Jeong CW
    Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e24-5. PubMed ID: 25257032
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
    Takahashi T
    Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Dong K, Shen M, Ju G, et al. Off-clamp Retroperitoneoscopic Tumour Evacuation for Sporadic Renal Angiomyolipomas with High RENAL Nephrometry Scores: A Novel Surgical Technique and Its Outcomes. Eur Urol 2021;79:283-289.
    Wang J; Li W; Xu B
    Eur Urol; 2021 May; 79(5):e151. PubMed ID: 33618846
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Scott Leslie, Inderbir S. Gill, Andre Luis de Castro Abreu, et Al. Renal tumor contact surface area: a novel parameter for predicting complexity and outcomes of partial nephrectomy. Eur urol 2014;66:884-93.
    Shin TY; Rha KH
    Eur Urol; 2014 Nov; 66(5):e93-4. PubMed ID: 24973997
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
    Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C
    Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.